-
1دورية أكاديمية
المؤلفون: Dragomir, A, Hesswani, C, Pouliot, F, Kapoor, A, Lavallée, L, Finelli, A, Rendon, R, Bhindi, B, Lattouf, JB, Lalani, AK, Heng, DYC, Bjarnason, GA, Breau, RH, Basappa, NS, Wood, L, Tanguay, S
المصدر: In Value in Health December 2022 25(12) Supplement:S52-S52
-
2دورية أكاديمية
المؤلفون: Bou-Nehme Sawaya, G, Dragomir, A, Kollmannsberger, C, Basappa, NS, Kapoor, A, Soulières, D, Finelli, A, Heng, DYC, Wood, L, Castonguay, V, Canil, C, Winquist, E, Graham, J, Bjarnason, GA, Bhindi, B, Lalani, AK, Pouliot, F, Breau, RH, Tanguay, S
المصدر: In Value in Health December 2022 25(12) Supplement:S39-S39
-
3دورية أكاديمية
المؤلفون: Graham J; CancerCare Manitoba, Division of Medical Oncology and Hematology, University of Manitoba, Winnipeg, MB, Canada. Electronic address: jgraham9@cancercare.mb.ca., Ghosh S; Department of Medical Oncology, Faculty of Medicine and Dentistry University of Alberta, Edmonton, AB, Canada., Breau RH; Division of Urology, University of Ottawa, Ottawa, ON, Canada., Wood L; Division of Medical Oncology, QEII Health Sciences Center, Halifax, NS, Canada., Tanguay S; Department of Surgery, McGill University, Montreal, QC, Canada., Bosse D; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Lalani AK; Division of Medical Oncology, McMaster University, Hamilton, ON, Canada., Bhindi B; Division of Urology, University of Calgary, Calgary, AB, Canada., Heng D; Division of Medical Oncology, University of Calgary, Calgary, AB, Canada., Finelli A; Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada., Fallah-Rad N; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Castonguay V; Centre de recherche du Centre Hospitalier Universitaire de Québec - Université Laval (CRCHUQc-UL), Centre de recherche sur le cancer (CRC) de l'Université Laval, Québec, QC, Canada., Basappa NS; Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada., Soulières D; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Pouliot F; Cancer Research Center, Centre Hospitalier Universitaire de Québec - Université Laval, Québec, QC, Canada., Kollmannsberger C; BC Cancer - Vancouver Centre, Vancouver, BC, Canada., Bjarnason GA; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Jun; Vol. 22 (3), pp. 102060. Date of Electronic Publication: 2024 Feb 23.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Anilides*/administration & dosage , Anilides*/adverse effects , Anilides*/therapeutic use , Pyridines*/administration & dosage , Pyridines*/adverse effects , Pyridines*/therapeutic use , Carcinoma, Renal Cell*/drug therapy , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/pathology , Protein Kinase Inhibitors*/administration & dosage , Protein Kinase Inhibitors*/adverse effects , Protein Kinase Inhibitors*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Canada ; Treatment Outcome ; Retrospective Studies ; Drug Tapering ; Adult ; Aged, 80 and over
-
4دورية أكاديمية
المؤلفون: Sawaya GB; Faculty of Medicine and Health Sciences, Department of Surgery, McGill University, Montréal, QC, Canada., Dragomir A; Faculté de Pharmacie, Université de Montréal, Montréal, QC, Canada. Electronic address: alice.dragomir@umontreal.ca., Wood LA; Queen Elizabeth II Health Sciences Center, Dalhousie University, Halifax, NS, Canada., Kollmannsberger C; British Columbia Cancer Care, Vancouver, BC, Canada., Basappa NS; Alberta Health Services, Edmonton, AB, Canada., Kapoor A; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Soulières D; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Finelli A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Heng DYC; University of Calgary, Calgary, AB, Canada., Castonguay V; Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC, Canada., Canil C; The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Winquist E; Department of Oncology, Western University and London Health Sciences Centre, London, ON, Canada., Graham J; Univeristy of Manitoba, Winnipeg, MB, Canada., Bjarnason GA; Sunnybrook Odette Cancer Centre, Toronto, ON, Canada., Bhindi B; University of Calgary, Calgary, AB, Canada., Lalani AK; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Pouliot F; Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC, Canada., Breau RH; The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Saleh R; McGill University Health Centre, Montréal, QC, Canada., Tanguay S; McGill University Health Centre, Montréal, QC, Canada.
المصدر: European urology oncology [Eur Urol Oncol] 2024 Jun; Vol. 7 (3), pp. 570-580. Date of Electronic Publication: 2023 Dec 13.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Renal Cell*/mortality , Carcinoma, Renal Cell*/therapy , Carcinoma, Renal Cell*/drug therapy , Carcinoma, Renal Cell*/secondary , Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/pathology , Kidney Neoplasms*/therapy , Kidney Neoplasms*/mortality , Kidney Neoplasms*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; Immunotherapy ; Retrospective Studies ; Survival Rate ; Molecular Targeted Therapy
-
5دورية أكاديمية
عنوان ترانسليتريتد: Percées dans la prise en charge de l’hypernéphrome.
المؤلفون: Cardenas LM; Département d'oncologie (Cardenas, Sigurdson, Lalani, Swaminath), Centre de cancérologie Juravinski, Université McMaster, Hamilton, Ont.; Division d'urologie, Département de chirurgie (Wallis), Université de Toronto; Division d'urologie, Département de chirurgie (Wallis), Hôpital Mont Sinaï; Département de chirurgie oncologique (Wallis), Réseau universitaire de santé, Toronto, Ont., Sigurdson S; Département d'oncologie (Cardenas, Sigurdson, Lalani, Swaminath), Centre de cancérologie Juravinski, Université McMaster, Hamilton, Ont.; Division d'urologie, Département de chirurgie (Wallis), Université de Toronto; Division d'urologie, Département de chirurgie (Wallis), Hôpital Mont Sinaï; Département de chirurgie oncologique (Wallis), Réseau universitaire de santé, Toronto, Ont., Wallis CJD; Département d'oncologie (Cardenas, Sigurdson, Lalani, Swaminath), Centre de cancérologie Juravinski, Université McMaster, Hamilton, Ont.; Division d'urologie, Département de chirurgie (Wallis), Université de Toronto; Division d'urologie, Département de chirurgie (Wallis), Hôpital Mont Sinaï; Département de chirurgie oncologique (Wallis), Réseau universitaire de santé, Toronto, Ont., Lalani AK; Département d'oncologie (Cardenas, Sigurdson, Lalani, Swaminath), Centre de cancérologie Juravinski, Université McMaster, Hamilton, Ont.; Division d'urologie, Département de chirurgie (Wallis), Université de Toronto; Division d'urologie, Département de chirurgie (Wallis), Hôpital Mont Sinaï; Département de chirurgie oncologique (Wallis), Réseau universitaire de santé, Toronto, Ont. swaminath@HHSC.CA lalania@hhsc.ca., Swaminath A; Département d'oncologie (Cardenas, Sigurdson, Lalani, Swaminath), Centre de cancérologie Juravinski, Université McMaster, Hamilton, Ont.; Division d'urologie, Département de chirurgie (Wallis), Université de Toronto; Division d'urologie, Département de chirurgie (Wallis), Hôpital Mont Sinaï; Département de chirurgie oncologique (Wallis), Réseau universitaire de santé, Toronto, Ont. swaminath@HHSC.CA lalania@hhsc.ca.
المصدر: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2024 May 05; Vol. 196 (17), pp. E601-E607. Date of Electronic Publication: 2024 May 05.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Canadian Medical Association Country of Publication: Canada NLM ID: 9711805 Publication Model: Electronic Cited Medium: Internet ISSN: 1488-2329 (Electronic) Linking ISSN: 08203946 NLM ISO Abbreviation: CMAJ Subsets: MEDLINE
مواضيع طبية MeSH: Kidney Neoplasms*/therapy, Humans ; Carcinoma, Renal Cell/therapy
-
6دورية أكاديمية
المؤلفون: Saad F; Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, QC, Canada., Hotte SJ; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Noonan K; BC Cancer Agency, University of British Columbia, Surrey, BC, Canada., Malone S; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada., Morash C; Jewish General Hospital, McGill University, Montreal, QC, Canada., Niazi T; Jewish General Hospital, McGill University, Montreal, QC, Canada., Rendon RA; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada., Shayegan B; St. Joseph's Healthcare, McMaster University, Hamilton, ON, Canada., Basappa NS; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Cagiannos I; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada., Danielson B; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Delouya G; Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, QC, Canada., Fernandes R; London Health Science Centre, Western University, London, ON, Canada., Ferrario C; Jewish General Hospital, McGill University, Montreal, QC, Canada., Finelli A; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Gotto GT; Southern Alberta Institute of Urology, University of Calgary, Calgary, AB, Canada., Hamilton RJ; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Izard JP; Kingston Health Sciences Centre, Queen's University, Kingston, ON., Kapoor A; St. Joseph's Healthcare, McMaster University, Hamilton, ON, Canada., Lalani AK; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Lavallée LT; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada., Ong M; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada., Pouliot F; Quebec City University Hospital Center & Centre de Recherche of Quebec City University Hospital Center, University of Laval, QC, Canada., So AI; Prostate Centre at Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada., Yip S; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Chi KN; BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada.
المصدر: Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2024 Apr; Vol. 18 (4), pp. E127-E137.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Canadian Urological Association Country of Publication: Canada NLM ID: 101312644 Publication Model: Print Cited Medium: Print ISSN: 1911-6470 (Print) Linking ISSN: 19116470 NLM ISO Abbreviation: Can Urol Assoc J Subsets: PubMed not MEDLINE
-
7دورية أكاديمية
المؤلفون: Cardenas LM; Department of Oncology (Cardenas, Sigurdson, Lalani, Swaminath), Juravinski Cancer Centre, McMaster University, Hamilton, Ont.; Division of Urology, Department of Surgery (Wallis), University of Toronto; Division of Urology, Department of Surgery (Wallis), Mount Sinai Hospital; Department of Surgical Oncology (Wallis), University Health Network, Toronto, Ont., Sigurdson S; Department of Oncology (Cardenas, Sigurdson, Lalani, Swaminath), Juravinski Cancer Centre, McMaster University, Hamilton, Ont.; Division of Urology, Department of Surgery (Wallis), University of Toronto; Division of Urology, Department of Surgery (Wallis), Mount Sinai Hospital; Department of Surgical Oncology (Wallis), University Health Network, Toronto, Ont., Wallis CJD; Department of Oncology (Cardenas, Sigurdson, Lalani, Swaminath), Juravinski Cancer Centre, McMaster University, Hamilton, Ont.; Division of Urology, Department of Surgery (Wallis), University of Toronto; Division of Urology, Department of Surgery (Wallis), Mount Sinai Hospital; Department of Surgical Oncology (Wallis), University Health Network, Toronto, Ont., Lalani AK; Department of Oncology (Cardenas, Sigurdson, Lalani, Swaminath), Juravinski Cancer Centre, McMaster University, Hamilton, Ont.; Division of Urology, Department of Surgery (Wallis), University of Toronto; Division of Urology, Department of Surgery (Wallis), Mount Sinai Hospital; Department of Surgical Oncology (Wallis), University Health Network, Toronto, Ont. swaminath@HHSC.CA lalania@hhsc.ca., Swaminath A; Department of Oncology (Cardenas, Sigurdson, Lalani, Swaminath), Juravinski Cancer Centre, McMaster University, Hamilton, Ont.; Division of Urology, Department of Surgery (Wallis), University of Toronto; Division of Urology, Department of Surgery (Wallis), Mount Sinai Hospital; Department of Surgical Oncology (Wallis), University Health Network, Toronto, Ont. swaminath@HHSC.CA lalania@hhsc.ca.
المصدر: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2024 Feb 25; Vol. 196 (7), pp. E235-E240. Date of Electronic Publication: 2024 Feb 25.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Canadian Medical Association Country of Publication: Canada NLM ID: 9711805 Publication Model: Electronic Cited Medium: Internet ISSN: 1488-2329 (Electronic) Linking ISSN: 08203946 NLM ISO Abbreviation: CMAJ Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Renal Cell*/surgery , Kidney Neoplasms*/surgery, Humans ; Nephrectomy
-
8دورية أكاديميةEmerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma.
المؤلفون: Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. Electronic address: chris_labaki@dfci.harvard.edu., Saliby RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Saad E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Eid M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lalani AK; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Braun DA; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT, USA.
المصدر: Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2023 Oct; Vol. 37 (5), pp. 937-942. Date of Electronic Publication: 2023 Jul 03.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-1977 (Electronic) Linking ISSN: 08898588 NLM ISO Abbreviation: Hematol Oncol Clin North Am Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Renal Cell*/drug therapy , Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/pathology, Humans ; Immunotherapy ; Biomarkers
SCR Disease Name: Clear-cell metastatic renal cell carcinoma
-
9دورية أكاديمية
المؤلفون: Millan B; Division of Urology, McMaster Institute of Urology, McMaster University, Hamilton, Ontario, Canada. Electronic address: braden.millan@medportal.ca., Breau RH; Division of Urology, University of Ottawa, Ottawa, Ontario, Canada., Mallick R; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada., Wood L; Division of Medical Oncology, QEII Health Sciences Center, Halifax, Nova Scotia, Canada., Rendon R; Department of Urology, Dalhousie University, Halifax, Nova Scotia, Canada., Finelli A; Division of Urology, University of Toronto, Toronto, Ontario, Canada., So AI; Department of Urologic Sciences, The University of British Columbia, Vancouver, British Columbia, Canada., Lavallée LT; Division of Urology, University of Ottawa, Ottawa, Ontario, Canada., Pouliot F; Division of Urology, CHU of Québec and Laval University, Montreal, Quebec, Canada., Bhindi B; Division of Urology, University of Calgary, Calgary, Alberta, Canada., Heng D; Division of Medical Oncology, University of Calgary, Calgary, Alberta, Canada., Drachenberg D; Division of Urology, University of Manitoba, Winnipeg, Manitoba, Canada., Tanguay S; Department of Surgery, McGill University, Montreal, Quebec, Canada., Dean L; Department of Surgery, Alberta Urology Institute Research Center, University of Alberta, Edmonton, Alberta, Canada., Basappa NS; Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta. Edmonton, Canada., Lattouf JB; Department of Surgery, University of Montreal, Montreal, Quebec, Canada., Bjarnason G; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Lalani AK; Division of Medical Oncology, McMaster University, Hamilton, Ontario, Canada., Kapoor A; Division of Urology, McMaster Institute of Urology, McMaster University, Hamilton, Ontario, Canada.
المصدر: Urologic oncology [Urol Oncol] 2023 Jul; Vol. 41 (7), pp. 328.e15-328.e23. Date of Electronic Publication: 2023 May 16.
نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE
-
10دورية أكاديمية
المؤلفون: Ernst MS; Department of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada., Navani V; Department of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada., Wells JC; Department of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada., Donskov F; Department of Oncology, Aarhus University Hospital & University Hospital of Southern Denmark, Esbjerg, Denmark., Basappa N; Cross Cancer Clinic, University of Alberta, Edmonton, Alberta, Canada., Labaki C; Dana-Farber Cancer Institute, Boston, MA, USA., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Meza L; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Wood LA; Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada., Ernst DS; London Regional Cancer Centre, London, Ontario, Canada., Szabados B; Barts Cancer Institute, Queen Mary University of London, London, UK., McKay RR; University of California San Diego, Moores Cancer Center, San Diego, CA, USA., Parnis F; Icon Cancer Centre, Adelaide, South Australia., Suarez C; Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Yuasa T; Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Lalani AK; Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada., Alva A; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Bjarnason GA; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA., Heng DYC; Department of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada. Electronic address: Daniel.Heng@AHS.ca.
المصدر: European urology [Eur Urol] 2023 Jul; Vol. 84 (1), pp. 109-116. Date of Electronic Publication: 2023 Jan 26.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/pathology, Humans ; Prognosis ; Vascular Endothelial Growth Factor A ; Retrospective Studies